Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
Drug Safety
|
July 4, 2020
Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
Linda Härmark, Gerda Weits, Rietje Meijer, et al.
Drug Safety
|
May 18, 2020
Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
Linda Härmark, Gerda Weits, Rietje Meijer, et al.
Drug Safety
|
April 14, 2017
The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
Leàn Rolfes, Florence van Hunsel, Laura van der Linden, et al.
Vaccines
|
August 28, 2025
Frequency, Timing, Burden and Recurrence of Adverse Events Following Immunization After HPV Vaccine Based on a Cohort Event Monitoring Study in the Netherlands
Monika Raethke, Jeroen Gorter, Rachel Kalf, et al.
Frontiers in Psychiatry
|
September 13, 2021
Drug-Induced Stuttering: Occurrence and Possible Pathways
Corine Ekhart, Florence van Hunsel, Peter van Harten, et al.
Pharmacoepidemiology and Drug Safety
|
December 3, 2009
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins
Florence van Hunsel, Eugène van Puijenbroek, Lolkje de Jong-van den Berg, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
April 8, 2014
Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands
Loes de Vries, Florence van Hunsel, Benedikte Cuppers-Maarschalkerweerd, et al.
Therapeutic Advances in Drug Safety
|
February 17, 2022
Diabetes patient's pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation
Cristiano Matos, Florence van Hunsel, Rogério Tavares Ribeiro, et al.
European Journal of Clinical Pharmacology
|
July 27, 2010
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
Florence van Hunsel, Christine van der Welle, Anneke Passier, et al.
Drug Testing and Analysis
|
February 22, 2023
An Indonesian slimming drug with undeclared ingredients causing harm
Sonja van de Koppel, Corine Ekhart, Chantal Roelen, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
Drug Safety
|
July 4, 2020
Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
Linda Härmark, Gerda Weits, Rietje Meijer, et al.
Drug Safety
|
May 18, 2020
Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
Linda Härmark, Gerda Weits, Rietje Meijer, et al.
Drug Safety
|
April 14, 2017
The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
Leàn Rolfes, Florence van Hunsel, Laura van der Linden, et al.
Vaccines
|
August 28, 2025
Frequency, Timing, Burden and Recurrence of Adverse Events Following Immunization After HPV Vaccine Based on a Cohort Event Monitoring Study in the Netherlands
Monika Raethke, Jeroen Gorter, Rachel Kalf, et al.
Frontiers in Psychiatry
|
September 13, 2021
Drug-Induced Stuttering: Occurrence and Possible Pathways
Corine Ekhart, Florence van Hunsel, Peter van Harten, et al.
Pharmacoepidemiology and Drug Safety
|
December 3, 2009
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins
Florence van Hunsel, Eugène van Puijenbroek, Lolkje de Jong-van den Berg, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
April 8, 2014
Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands
Loes de Vries, Florence van Hunsel, Benedikte Cuppers-Maarschalkerweerd, et al.
Therapeutic Advances in Drug Safety
|
February 17, 2022
Diabetes patient's pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation
Cristiano Matos, Florence van Hunsel, Rogério Tavares Ribeiro, et al.
European Journal of Clinical Pharmacology
|
July 27, 2010
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
Florence van Hunsel, Christine van der Welle, Anneke Passier, et al.
Drug Testing and Analysis
|
February 22, 2023
An Indonesian slimming drug with undeclared ingredients causing harm
Sonja van de Koppel, Corine Ekhart, Chantal Roelen, et al.
Page
of 10